CCL2 and neoplasm: To investigate the effect of CCL2 on tumour latency in the Mmtv-PyMT mouse model, PyMT controls and PyMT/CCL2 mice were monitored for the emergence of palpable tumours weekly from 6 weeks of age, and sacrificed at either 9 or 12 weeks of age for analysis.